OPKO Health Announces Listing in Major Indices on Tel Aviv Stock Exchange

Aug 28, 2013

OPKO Health Announces New Listing on Tel Aviv Stock Exchange

Aug 19, 2013

OPKO Surpasses 50% Enrollment in Second Phase 3 Trial of Rayaldy™

Aug 15, 2013

OPKO Announces Second Quarter 2013 Operating and Financial Highlights

Aug 9, 2013

OPKO’s Citicoline Products Approved for Commercialization in Spain

Jul 24, 2013

OPKO Health Announces Appointment of David Okrongly, Ph.D. as President of its Diagnostics Business Unit

Jul 16, 2013

OPKO Health to Present at the Jefferies 2013 Global Healthcare Conference

May 30, 2013

OPKO Surpasses 50% Enrollment in First Phase 3 Trial of RayaldyTM (CTAP101 Capsules)

May 23, 2013

OPKO Announces First Quarter 2013 Operating and Financial Highlights

May 9, 2013

OPKO Health Acquires Interest in Growing Russian Pharmaceutical Company

Apr 18, 2013